Meldopharm (Meldonium Dihydrate)

Meldonium blocks the enzyme gamma‑butyrobetaine hydroxylase, which is essential for synthesising carnitine. Lower carnitine levels reduce fatty‑acid oxidation in heart muscle cells and promote glucose oxidation, a more oxygen‑efficient energy pathway. This metabolic re‑programming enhances myocardial performance during ischemic stress.

The dosage of Meldopharm is individualized by the prescribing clinician based on the patient’s condition, severity of disease, and response to therapy. The prescriber determines the appropriate strength, frequency, and duration, and patients should follow the written prescription without alteration.

Safety data for meldonium during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Consequently, it is generally avoided in pregnant or nursing women unless the potential benefit justifies the potential risk, as assessed by a qualified healthcare professional.

To request Meldopharm, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Meldopharm (meldonium) belongs to the metabolic modulator class, whereas the most common alternative, trimetazidine, also shifts myocardial metabolism toward glucose but acts through inhibition of fatty‑acid β‑oxidation at the mitochondrial level. Both improve cardiac efficiency, but their enzymatic targets differ, which may influence individual patient response and tolerability.

Meldopharm should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments to maintain stability and potency.

Meldopharm is administered orally, typically as a tablet or capsule taken with a glass of water. It may be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure consistent absorption and therapeutic effect.

The most serious adverse reactions associated with Meldopharm include new or worsening cardiac arrhythmias, severe hypotension, and allergic responses such as rash, pruritus, or angioedema. Patients should seek immediate medical attention if they experience palpitations, a sudden drop in blood pressure, or signs of an allergic reaction.

Meldopharm is contraindicated in patients with known hypersensitivity to meldonium or any of its excipients. It should also be avoided in individuals with severe renal or hepatic impairment, and in pregnant or breastfeeding women due to insufficient safety data. Clinicians must evaluate each patient’s medical history before initiating therapy.